The new Samsung One UI 7 has been teased but not given to Galaxy Z Fold 6 and Flip 6 owners, until now. At last it seems that the still-quite-new UI is beginning to appear on devices, in North ...

Mark Gurman has once more suggested a 2026 release window for the rumored iPhone Fold, adding his own not-insignificant influence to the cascade of other analysts saying the same thing.

The Samsung Galaxy Z Fold 6 is a fantastic foldable phone – it’s arguably the best widely available foldable Samsung has so far made, and it ranks among the best foldable phones from any brand.

Samsung has pushed the third Android 15 beta firmware for Z Fold 6 and Flip 6 with bug fixes and new features. The update includes the ability to trigger Gemini by pressing a side button and the ...

White House National Security Adviser Mike Waltz, left, speaks with Secretary of Defense Pete Hegseth in Washington on Feb. 24: Both were involved in Signals chat now under scrutiny. (Ludovic ...

Last week, we covered a report claiming that Apple's book-style foldable iPhone (or "iPhone Fold," as we are provisionally calling it here) will use liquid metal hinges to improve durability and ...

From book style to tri-fold, here’s everything which you can expect to launch in the upcoming months. Samsung Galaxy Z Fold 7, Motorola Razr 60, and several other foldable phones are launching ...

When cutaneous features such as malar rash, discoid lesions, and photosensitivity are present, rheumatologists are more likely to turn to biologics, most notably AstraZeneca’s Saphnelo ...

Bilateral eye pain, redness and itching occurred after onset of rash and subsided with resolution of rash. Figure 1. Injection of left eye at time of flare. Source: Varsha Pramil, MD, and Lianna ...

Apple’s highly anticipated entry into the foldable smartphone market, the iPhone Ultra Fold, is rumored to make its debut next year. While the company has yet to make an official announcement ...

When cutaneous features such as malar rash, discoid lesions, and photosensitivity are present, rheumatologists are more likely to turn to biologics, most notably AstraZeneca's Saphnelo ...